
Balancing innovation and efficiency in clinical trials: Is t...
Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes


Exploring the future: Opportunities and challenges in cell a...
Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.

Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and

Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

JP Morgan Week 2025 – Phil Johnson
Phil Johnson chat about why he joined Evidation and his excitement about the company’s mission.

Life Sciences Industry Report - Part 5
Developments in the oncology space in 2024 brought hope to both industry and patients.

7th Neuroimmunology Drug Development Summit
7th Neuroimmunology Drug Development Summit | February 25-27 2025 | Boston, MA

3rd Precision Medicine in Inflammatory Bowel Disease Summit ...
Following a year of exceptional progress in IBD drug development, fierce competition in clinical trials for Chron’s Disease and Ulcerative Colitis remains high, and it’s time for biopharma to push